Newsroom Archive

MedCity FemFwd: What the Future Holds for Women’s Health in 2025

MedCity News, December 29, 2024

SWHR President and CEO Kathryn Schubert discusses the trends in women’s health that defined 2024 and what we can expect in the coming year in this podcast.

Partnerships in Clinical Trials | Episode 1

SCDM Podcast, December 17, 2024

SWHR President and CEO Kathryn Schubert speaks with SCDM Chair Patrick Nadolny about the critical alliances between key stakeholders in the industry, with a lens on women’s health.

Q&A with Irene Aninye, Chief Science Officer of the Society for Women’s Health Research

Springer Nature, December 11, 2024

This interview with SWHR Chief Science Officer Irene Aninye accompanies her editorial in the journal Biology of Sex Differences and explores the Society’s goals in relation to the SDGs.

Bridging the Gap in Women’s Health Research

The Wilson Center, December 10, 2024

SWHR Chief Science Officer Irene Aninye joined a panel of women’s’ health experts to discuss how to close research gaps & improve women’s health globally.

Employee Engagement & Well-Being

IELA Digital, December 2024

This report focusses on employee mental and physical health, financial well-being, and women’s health, and includes valuable insights from SWHR President and CEO Kathryn Schubert on the role of supporting women’s midlife health in the workplace.

NIH needs a new institute for women’s health research, expert panel says

Science Magazine, December 5, 2024

SWHR President and CEO Kathryn Schubert shares reactions to a recently NASEM report about women’s health research at the NIH.

A New Era of Women-Centric Health Research

Next Avenue, December 3, 2024

SWHR Chief Science Officer Irene Aninye discusses how gaps in women’s health research have impacted women’s health outcomes from heart health to Alzheimer’s disease, and more.

Why funding women’s health shouldn’t be up for debate

Fast Company, November 26, 2024

In this Impact Council Op Ed, SWHR President and CEO Kathryn Schubert joins Perelel co-founder Alex Taylor to call for increased funding for and focus on women’s health research.

In divide on women’s health care, a consensus on menopause

CQ Roll Call, November 13, 2024

SWHR President and CEO Kathryn Schubert is included in this reporting menopause advocacy and legislation, noting that “support for federal research on menopause spans both sides of the aisle, and other women’s health issues, like research on conditions such as endometriosis, are emerging in a similar way.”

Democrats worry over fate of women’s health research if Trump reelected: ‘He’s actively working against us’

The Hill, November 1, 2024

SWHR President and CEO Kathryn Schubert provided comments for this article about the work to get women’s health research funding through Congress. “All policymakers should recognize the value of investing in women’s health research,” she said in the article.

The Suffragist for Gender Equity in Health-Care Research

Association for Women in Science, Fall 2024

SWHR President and CEO Kathryn Schubert was profiled in the fall 2024 issue of the Association for Women in Science Magazine.

IVF Restrictions, Demise of Roe v. Wade Could Endanger Women’s Health Research

BioSpace, September 30, 2024

SWHR President and CEO Kathryn Schubert explains how historic exclusion of women in medical research has impacted health outcomes and access today.

Women’s pain and discomfort has a history of being ignored in health care. Here are 2 ways that’s starting to change.

Yahoo Life, August 23, 2024

SWHR Chief Science Officer Irene Aninye explained how the history of women’s health research has impacted women’s pain treatment and research today.

Women are more likely to die from cancer in the southern U.S

Axios, July 18, 2024

SWHR Chief Science Officer Irene Aninye provided comments about trends in cancer screening guidelines and care access for women across the country.

Rising Cancer Rates: What is causing the surge in cancer among young people?

CQ Researchers, July 12, 2024

SWHR Chief Science Officer Irene Aninye provided comments for a report about rising cancers rates in individuals and particularly women.

Shared decision-making critical for managing polycystic ovary syndrome

Healio, July 10, 2024

SWHR’s PCOS webinar was featured in this article about shared decision-making and PCOS care.

Shining a Light On Fibroids During Fibroid Awareness Month

Signature Bride, July 5, 2024

SWHR’s uterine fibroids resources were featured in this article about fibroids awareness.

‘A watershed moment’ for a shadow disease: first state-mandated endometriosis biorepository launches in Connecticut

Science, June 10, 2024

SWHR President and CEO Kathryn Schubert spoke to Science about the state of endometriosis funding and the need for greater visibility, research, and treatment for this uterine health condition.

The Business of America Ep. 21 – Emily Holubowich & Katie Schubert

The Federal Newswire Podcast, May 16, 2024

SWHR President and CEO Kathryn Schubert joined heart health leader Emily Holubowich and host Jerry Rogers to talk about advocating for women’s health, including women in clinical trials, and supporting women’s heart health across the lifespan.

FDA approves self-collection screening for virus that causes cervical cancer

The Washington Post, May 15, 2024

SWHR Chief Science Officer Irene Aninye provided comments about the potential that self-collection HPV screenings would have on closing gaps and improving women’s health.

Women’s Health: Where Politics and Science Meet

BioSpace Podcast, May 9, 2024

SWHR President and CEO Kathryn Schubert joined other leaders in women’s health research and femtech to discuss how new funding in the space could be used to help improve clinical trial inclusion for women. This is the third podcast is a three-part series on the topic.

Washington DC’s 500 Most Influential People of 2024

Washingtonian, May 2, 2024

SWHR President and CEO Kathryn Schubert was named one of Washington DC’s 500 Most Influential People of 2024 in healthcare, as a “leading pro who knows the ins and outs of healthcare policy, regulation, and access—and how those can help or hurt consumers.”

Boston Public Radio Live

GBH News, May 1, 2024

SWHR President and CEO Kathryn Schubert joined Boston Public Radio hosts and Jamie Belsito, Founder of Maternal Mental Health Leadership Alliance, for a live women’s health panel at the start of Women’s Health Month.

National Academies Committee Plans for Expanding Women’s Health Research at NIH

NIH Record, April 26, 2024

SWHR Chief Advocacy Officer Lindsey Miltenberger shares reflections following a recent National Academies meeting that seeks to review women’s health research at the NIH.

Where Do We Go From Here? The Future of Women’s Health

BioSpace Podcast, April 25, 2024

SWHR President and CEO Kathryn Schubert joined other leaders in women’s health research and femtech to discuss how new funding in the space could be used to help improve clinical trial inclusion for women. This is the second podcast is a three-part series on the topic.

Maria Shriver talks teaming with Jill Biden to push for gender equity in medical research: It’s not political, it’s a ‘human issue’

The Hill, April 24, 2024

The Society co-hosted The Power of Research: The Need for Gender Equity luncheon with Maria Shriver and the Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic to bring attention to the gender equity gap in health research and the impact of Alzheimer’s disease on women. This article covered the event and Shriver and WAM’s work in the space.

Will a New Government Initiative Really Bridge the Gap in Women’s Health Research?

Health Central, April 22, 2024

SWHR Chief Advocacy Officer Lindsey Miltenberger spoke about the state of women’s health research and how new government initiatives can help close historic gaps.

Families often have chief medical officers – and they’re almost always women

American Heart Association, April 17, 2024

SWHR Chief Advocacy Officer Lindsey Miltenberger spoke with AHA about how women’s role as the main health care decision-maker for their families impacts their own health outcomes.

It’s a Design Problem: Women and Clinical Trials

BioSpace Podcast, April 11, 2024

SWHR President and CEO Kathryn Schubert joined other leaders in women’s health research and femtech to discuss how new funding in the space could be used to help improve clinical trial inclusion for women. This is the first podcast is a three-part series on the topic.

Can $12 Billion Jumpstart Women’s Health?

BioSpace, April 10, 2024

SWHR President and CEO Kathryn Schubert spoke with BioSpace about the future of women’s health research following the announcement of the White House Initiative on Women’s Health Research.

New federal report calls out clinical trials for excluding pregnant women

The Fuller Project, April 10, 2024

SWHR Chief Science Officer Irene Aninye provided comments on a new NASEM report that pushes back on the notion that pregnant individuals should be excluded from research.

President Biden Wants To Rectify the State of Women’s Health Research—but What Will It Take To Catch Up?

Well+Good, April 7, 2024

SWHR President and CEO Kathryn Schubert shared how the new White House Initiative on Women’s Health Research will help accelerate women’s health research as well as what women can do to advocate for themselves in the health care system.

Why Heart Disease Research Still Favors Men

TIME, April 5, 2024

Dr. Martha Gulati’s presentation during the SWHR “Getting at the Heart of Needs in Women’s Heart Health” webinar is featured in this article. Dr. Gulati is a member of SWHR’s Heart Health Working Group.  New federal report calls out clinical trials for excluding pregnant women.

Mira Introduces First Nationwide Sex Hormones Awareness Week to Close the Knowledge Gap About Female Hormones

PR Newswire, February 19, 2024

The Society was a partner organization for Mira’s first nationwide Sex Hormones Awareness Week.

Helping women with heart disease

CNN, February 13, 2024

The Society is listed as an organization supporting women’s heart health  in this article, spotlighting ways women are impacted by heart disease and how we can support them.

Managing and treating uterine fibroids| Line One: Your Health Connection

Alaska Public Radio (PBS | NPR), February 7, 2024

SWHR‘s uterine fibroids resources are featured in this article about treatment and care options for fibroids patients.

Nearly 2 in 5 Women Consider Quitting Job Due to Menopause

The Messenger, January 19, 2024

SWHR President and CEO Kathryn Schubert discussed the Employee Perspectives and Challenges Concerning the Transition of Menopause (EMPACT Menopause) Study and insights about menopause in the workplace. SWHR Working Group Member Jennifer Fairweather is also featured in the article.

What to Know About Complementary Treatments for Lupus

TIME, January 17, 2024

SWHR‘s Living with Lupus Toolkit is featured at the close of this article about the variety of lupus treatments available for individuals.

Closing the Gap: Addressing Unmet Needs and Research Gaps with the Society for Women’s Health Research – Ep. 222

FemTech Focus Podcast, November 22, 2023

SWHR President and CEO Kathryn Schubert interviewed for the FemTech Focus Podcast to talk all about promoting research on biological sex differences in disease and improving women’s health through science, policy, and education.

Sex Matters: Medical Research Overlooks Women

The Fuller Project, November 20, 2023

SWHR President and CEO Kathryn Schubert and Chief Science Officer Irene Aninye, alongside several other leading experts in women’s health, discussed what is still needed to close the health research gap.

Why Women’s Health is Different

MassBio, November 6, 2023

SWHR President and CEO Kathryn Schubert joined the MassBio symposium “Why Women’s Health is Different” to speak about the unique challenges in women’s health. MassBio CEO and President Kendalle Burlin O’Connell wrote up this summary blog.

Empowering Women at Work: Navigating Menopause with SWHR’s CEO

Be Health Connected Podcast, October 27, 2023

SWHR President and CEO Kathryn Schubert sat down to discuss the significance of menopause, its impact in the workplace, and what employers can do to create more supportive workplace environments for midlife and menopausal women.

Research and treatment still inadequate for endometriosis

Republican American, September 8, 2023

SWHR Chief Science Officer Irene O. Aninye provided comments on the significance of advancing research and treatment funding for endometriosis, and the positive impacts this will have on the lives of those living with the disease.

The Gender Research Gap

FemTech World Podcast, August 23, 2023

SWHR President and CEO Kathryn Schubert discussed gender inequalities between men and women that exist in medical research, and their consequences.

Oppenheimer revealed the human and political sides of science

Axios, July 21, 2023

SWHR President and CEO Kathryn Schubert provided comments about how older cultural norms impacted women’s health research and helped maintain a sex and gender research gap, that we still see today.

The Most Common Menopause Symptoms You Should Know

Health Day, June 15, 2023

SWHR‘s Menopause Preparedness Toolkit is featured at the close of this article about common menopause symptoms.

‘Just do kegels’ is tired. What’s next for this hot women’s health market?

Los Angeles Times, May 30, 2023

The Society provided commentary about the status of women’s health funding levels for this article about pelvic health care, research, and innovations.

Honoring Mothers: How the Society for Women’s Health Research Supports Women Caregivers

Modern Medicaid Alliance, May 25, 2023

The Modern Medicaid Alliance highlighted SWHR‘s work in maternal health including the health toll that caregiving can take on women across the lifespan.

How menopause reshapes the brain

Nature, May 3, 2023

SWHR President and CEO Kathryn Schubert spoke with authors about the status, stigma, and future of menopause research and care.

5 Myths About Pregnancy We All Need to Stop Believing

Prevention, April 16, 2023

SWHR President and CEO Kathryn Schubert provided expert response to myths around epidural and c-section deliveries in this story.

A Lifetime of Healthy Bones

VoiceAmerica, April 12, 2023

SWHR Working Group Member Deborah M. Kado, MD, MS spoke on the Able Active Moms radio show about lifelong bone health.

Menopause, from A to Z

Oprah Daily, April 5 2023

SWHR Chief Science Officer Irene O. Aninye gives tips for navigating the menopause transition and having productive conversations with care providers about your symptoms, treatment options, and lifelong wellness.

Closing the Gap

American Medical Technologists, March 22, 2023

SWHR President and CEO Kathryn Schubert spoke about the history of, dangers within, and opportunities to close the gender gap in health care research and medicine.

Here’s How the Medical System Overlooks Women’s Health

TheSkimm, March 8, 2023

SWHR President and CEO Kathryn Schubert shares how historic gaps in the medical and research ecosystems have hindered women’s health today, and what women can do to advocate for themselves.

Preeclampsia Raises Heart Attack and Stroke Risk

Giddy, March 7, 2023

SWHR Board Member Judette Louis, MD explains what to look for to understand your risk of heart problems or stroke after experiencing preeclampsia.

‘We’re not a world of men – it’s as simple as that’: how gender diversity in clinical trials improves health outcomes for women

GSK: Behind The Science Magazine, March 6, 2023

SWHR President and CEO Kathryn Schubert discusses the state of women’s health research and inclusion of women in clinical trials in this piece.

How Doctors Can Care for Women Better

WebMD, February 27, 2023

SWHR Chief Science Officer Irene O. Aninye is featured in this article discussing the importance of including women in clinical trials and advancing women’s health research.

Promoting the Inclusion of Women in Clinical Trials

Elevance Health, February 20, 2023

SWHR President and CEO Kathryn Schubert discusses the history of women’s health research and including women in clinical trials, explaining SWHR’s role in improving outcomes for women across the lifespan and throughout medicine and science.

These Founders Were Sick of Being Told They Weren’t Sick—And Now Their Work Is Driving Real Progress in Women’s Health

Well + Good, February 2023

SWHR President and CEO Kathryn Schubert is included in this article about leader within the women’s health space who have set out to create new tech and services to improve the quality of care women receive.

Medical gaslighting is real – and here’s how to fight it

WmnHealth.org, January 24, 2023

SWHR President and CEO Kathryn Schubert spoke about the history of women’s health research and stigma around women’s health – as well as ways women can have more productive provider conversations.

How To Talk to Your Doctor About Lupus: 4 Tips From an Expert

MyLupusTeam, January 24, 2023

SWHR’s Lupus Toolkit is featured in this article, alongside an interview with SWHR Lupus Working Group member Irene Blanco, MD.

The only cancer that won’t get covered for women of 9/11

The Fuller Project, January 10, 2023

SWHR Chief Science Officer Irene O. Aninye spoke about the research, fundings, and care gap for uterine cancer, and how this impacts women’s health outcomes over their lifespanc.

Menopause Matters Magazine: Being Prepared and Empowered

Menopause Matters Magazine, Winter 2022

SWHR’s Menopause Preparedness Toolkit is featured in the winter issues of the Menopause Matters Magazine, as a resource for women facing the menopause transition.

Menopause Education and Awareness Throughout the Menopause Journey

FutureofPersonalHealth.com, December 28, 2022

SWHR President and CEO Kathryn Schubert explains how improved menopause education and expanded conversations can help support women throughout the menopause transition and beyond.

Why We Should Focus on Women’s Health Research

Beyond the Paper Gown podcast, December 9, 2022

SWHR President and CEO Kathryn Schubert joined this women’s health podcast to talk about why inclusion in clinical trials is important and how biological sex, even at the cellular level gives clues to disease, which can impact diagnosis and treatment.

Health systems make a play for women

North Carolina Health News, November 14, 2022

SWHR President and CEO Kathryn Schubert spoke about the growing interest in women’s health, across health systems, funding, and research spaces. The article is also syndicated by Becker’s Hospital Review.

Women’s health got worse in 2021, global survey finds

CNN, September 21, 2022

SWHR President and CEO Kathryn Schubert spoke to a reporter about what new survey findings mean for the status of women’s health across the world and in the United States.

The Gospel of Wellness

Rina Raphael, September 2022

SWHR President and CEO Kathryn Schubert and the work of SWHR is included in this book about the rise of the wellness industry and its effects on women’s health.

A Bipartisan Bill Would Boost NIH’s Research on Menopause

Government Executive, September 7, 2022

The Society provided comment to Government Executive about a new bipartisan that would improve federal medical research related to menopause and mid-life women’s health.

As Title IX’s first generation ages, research needed to identify effects of playing sports

USA Today Sports, August 20, 2022

SWHR President and CEO Kathryn Schubert provided comment about the progress and gaps in women’s health research for a USA Today Sports Opinion article women’s inclusion in sports access and research.

“God, No, Not Another Case.” COVID-Related Stillbirths Didn’t Have to Happen.

ProPublica, August 4, 2022

SWHR President and CEO Kathryn Schubert spoke with ProPublica reporter Duaa Eldeib about the importance of including women in clinical trial research in order to improve health outcomes, particularly in the the case of the COVID-19 pandemic and related vaccine trials.

SWHR President and CEO Kathryn Schubert speaks with CGTN | July 2022

CGTN, July 2022

SWHR President and CEO Kathryn Schubert spoke with CGTN about the history of women’s health, its progress and barriers, and how this affects health outcomes for women particularly in the field of cardiovascular health and heart disease.

Struggle to include women in clinical trials continues despite gains

The Science Advisory Board, June 12, 2022

SWHR President and CEO Kathryn Schubert spoke with The Science Advisory Board about women’s health research while at the BIO 2022 conference.

Evvy Launches First Inaugural Equal Research Day

Yahoo News, June 10, 2022

The Society for Women’s Health Research is the nonprofit partner for the inaugural Equal Research Day on June 10, 2022, hosted by Evvy to drive awareness of including women in health research. Read more about Equal Research Day in Forbes and CEO World Magazine.

Katie Schubert: Making women’s health mainstream through research

Organon Here for Her Health Podcast, June 9, 2022

SWHR President and CEO Kathryn Schubert spoke about her career in women’s health and policy, her role at SWHR, and the work of making women’s health mainstream during this podcast interview.

The Gender Pain Gap: Why Women’s Pain Isn’t Taken as Seriously

Good Housekeeping, May 20, 2022

SWHR President and CEO Kathryn Schubert spoke about women’s pain and gave tips for ensuring women’s pain is taken seriously in medical settings.

World Economic Forum: Women’s Health Transformation Map

World Economic Forum, May 2022

SWHR is featured in the Women’s Health Transformation Map, managed by the WEF’s Strategic Intelligence group. This virtual map collects a wide range of women’s health information from across organizations, including SWHR resources and blogs.

The Value of Prevention in Combatting Cervical Cancer

FutureofPersonalHealth.com, March 31, 2022

SWHR President and CEO Kathryn Schubert shares ways we can advance cervical cancer care in the United States by expanding access and improving health outcomes for women affected by the gynecologic disease.

A look at the current state of uterine fibroid care

Contemporary OB/GYN, February 10, 2022

SWHR Chief Science Officer Irene O. Aninye discusses a recent SWHR paper in Journal of Women’s Health, which reviewed of the current state of research and clinical care for uterine fibroids and highlighted opportunities for improvement.

“Well Mama” Maternal Health Limited Series | Binary Gender Dynamics with Dr. Kathryn Schubert

Well Mama Podcast, February, 2022

SWHR President and CEO Kathryn Schubert shares about the work of SWHR, its goals to improve women’s health through science, policy and education, and its efforts to advance maternal health equity.

From vaginal laser treatment to spa breaks – it’s the great menopause gold rush

The Guardian, January 26, 2022

SWHR Chief Science Officer Irene O. Aninye discusses the stigma that women living through menopause face and the gaps in care that persist for the perimenopause, menopause, and post-menopause journeys.

Never Got the HPV Vaccine? Talk to Your Doctor if You’re Under 45

Giddy, January 24, 2022

SWHR Chief Science Officer Irene O. Aninye discusses the HPV prevention options and care opportunities available for individuals, and the importance of speaking with your doctor in order to inform the best HPV treatment plan for you.

Women’s Health Data Gets Focus in FDA Device Research Initiative

Bloomberg Law, January 18, 2022

SWHR President and CEO Kathryn Schubert provides commentary on the importance of including women’s health data collection and analysis goals in the new device research guidelines from FDA, based in an great need to include more in health and medical device research.

This is Why Women are Going Undiagnosed With ADHD and ASD

Medium, January 15, 2022

SWHR Chief Science Officer Irene O. Aninye highlights the need to include women in medical research at all stages and the urgent need to invest in women’s health research.

How medicine mansplained women’s health

Vox Unexplainable Podcast, December 8, 2021

SWHR Founder Florence Haseltine shares the story of the women who fought to have women included in clinical drug trials, including the founding of the Society of Women’s Health Research, and what we still don’t know about how sex and gender affect health.

Booker, Capito Introduce Legislation to Tackle Uterine Fibroids through Research, Education

Senate Press Release, July 23, 2021

SWHR President and CEO Kathryn Schubert provided comments for a Senate press release introducing the Stephanie Tubbs Jones Uterine Fibroid Research and Education Act, legislation, which would create research and public education programs to support women suffering from uterine fibroids.

Is There Gender Bias in the Treatment of Chronic Pain?

Health Central, May 10, 2021

SWHR President and CEO Kathryn Schubert discusses the gender gap in chronic pain, including how many invisible pain conditions, where the cause of pain may not be immediately physically obvious, like migraine and endometriosis, disproportionately affect women and are subject to intense stigma.

J&J’s Second Act Creates New Challenge for Immunization Effort

Bloomberg, April 26, 2021

SWHR President and CEO Kathryn Schubert explains the role women play in influencing medical decisions, and the risks and benefits women need to clearly understand before making health care decisions for their families and communities.

“Irregular menstrual cycle” isn’t listed as a COVID-19 vaccine side effect — but many report it

Salon.com, April 16, 2021

SWHR President and CEO Kathryn Schubert tells Salon she thinks questions about a woman’s menstrual cycle should “absolutely” be incorporated and an expected standard in clinical trials that include women.

Sex and gender differences in osteoarthritis with Dr Melissa Laitner

Joint Action Podcast, April 2, 2021

Melissa Laitner, PhD, MPH, SWHR’s former Director of Public Policy and Government Affairs, is a guest on this podcast to discuss SWHR’s review paper on gender disparities in osteoarthritis and how understanding the influence of sex and gender differences can help improve osteoarthritis research and clinical care.

Endometriosis experiences: The long, painful road to diagnosis

Medical News Today, March 30, 2021

This article cites SWHR 2019 paper published in the American Journal of Obstetrics and Gynecology emphasizing that women who seek care for endometriosis face a barrage of obstacles, including poor doctor-patient dynamics and a lack of effective treatments.

Gender and Alzheimer’s: Study Finds Harmful Proteins Accumulate Faster in Women’s Brains

Being Patient, March 29, 2021

This articles notes SWHR’s work advocating for better incorporation of sex as a biological variable (SABV) into Alzheimer’s preclinical research and references SWHR’s editorial on the topic in Alzheimer’s & Dementia: Translational Research & Clinical Interventions.

The latest in endometriosis research: Ways forward

Medical News Today, March 17, 2021

This article references SWHR’s 2019 review paper stating that despite the high prevalence and emotional and economic impact associated with endometriosis, endometriosis remains underfunded and, therefore, under-researched.

Research Insights: How to Address Osteoarthritis Treatment Gaps in Women

Practical Pain Management, March 2, 2021

Melissa Laitner PhD, MPH, SWHR’s former Director of Public Policy and Government Affairs and lead author of the paper, spoke to PPM about SWHR’s review paper on sex and gender differences in osteoarthritis and how we can move OA care forward for women.

Pregnant people weren’t included in the Covid vaccine studies. So how do they decide about the shot?

KUOW, February 10, 2021

SWHR President and CEO Kathryn Schubert talks about the longstanding obstacles to the inclusion of pregnant women in clinical research because of fears of what drugs might do to a developing fetus.

Why Sleep Is More of a Struggle For Women, Especially During COVID-19

Popsugar, December 22, 2020

Women suffer from certain sleep disorders more than men. Now, the COVID-19 pandemic is exacerbating these sleeping difficulties. This article highlights SWHR’s blog on the state of women’s sleep during the pandemic.

Pregnant Women Must Be Included in Medical Research

Scientific American, December 19, 2020

SWHR President and CEO Kathryn Schubert discusses the importance of including pregnant and lactating people in medical research in this commentary.

It’s the sexism, stupid.

Politico, December 11, 2020

“Self-awareness and understanding not just your own personality but those around you is critical to success … feedback is an opportunity for growth and learning,” SWHR President and CEO Kathryn Schubert says in Politico’s Women Rule newsletter.

Women are More Likely to Suffer Sleepless Nights in the U.S. and Europe, Study Finds

Forbes, November 18, 2020

Studies have shown that women are more likely to struggle to fall asleep. This article references SWHR’s work indicating that women are more likely to suffer from certain sleep disorders such as restless leg syndrome, or have an overactive bladder that can keep them up during the night.

Why do we know so little about women’s health?

The Boar, November 14, 2020

Between the 1970s and the 1990s, most women of reproductive age were excluded from medical research. However, the FDA and NIH both made it compulsory for women to be included in medical research in 1993, in response to SWHR’s years of campaigning.

Covid Kills More Men Than Women. Experts Still Can’t Explain Why

Wired, July 9, 2020

SWHR President and CEO Kathryn Schubert discusses possible explanations for why more men than women are dying from COVID-19. Months into the pandemic, it is still unclear why the novel coronavirus affects women and men differently.

Why Do Women Suffer More With Insomnia?

Forbes, June 17, 2020

Drawing on information from SWHR’s sleep health paper, this article examines sex differences in sleep disorders. Studies have shown that women are more likely to suffer from certain sleep problems like insomnia.

Kathryn Schubert Takes On CEO Of Society For Women’s Health Research

Biotech Metropolitan Women, June 15, 2020

This article discusses SWHR President and CEO Kathryn Schubert’s new position at SWHR and her efforts to create a strategic plan to fulfill SWHR’s vision of normalizing women’s health research.

Ignoring sex in medical research is ignoring women’s lives

Women’s Agenda, June 10, 2020

SWHR President and CEO Kathryn Schubert explains how making sex-based research analysis the norm in science and medicine on both the university level and the individual researcher level need will help advance sex as a biological variable (SABV) research.

Women Still Left Out of Much Medical Research

U.S. News, June 9, 2020

SWHR President and CEO Kathryn Schubert discusses the importance of including women in medical research in response to a new study shows that although some progress has been made on inclusion of female subjects in research, scientists are still not consistently analyzing data for sex differences, impeding our understanding of how biological differences between women and men influence health and disease.

For Rep. Abby Finkenauer, Advancing Endometriosis Research Is Personal

Mic.com, May 28, 2020

Former SWHR leadership Drs. Lucy Erickson and Melissa Laitner weigh in on the barriers to endometriosis diagnosis and treatment in a recent Mic.com article about Rep. Abby Finkenauer’s experience with the condition and her founding of a new House Endometriosis Caucus.

Coronavirus Testing Delays Yield New Oversight Bill, Shine Light on LDT Regulation Debate

GenomeWeb, March 16, 2020

Lawmakers introduced a bill that would vastly change oversight for diagnostics and give the FDA explicit authority to regulate tests developed by labs. Former SWHR CEO Dr. Amy M. Miller spoke with GenomeWeb about the VALID Act’s implications.

Congresswoman Abby Finkenauer Opens Up About Her Struggle With Endometriosis

Glamour, March 5, 2020

Like 1 in 10 women worldwide, Rep. Abby Finkenauer has endometriosis, an often-debilitating gynecological condition that can cause infertility and pelvic pain. Read her story in this Glamour article, which cites SWHR’s paper on gaps in endometriosis research and care and quotes lead author Dr. Suzie As-Sanie.

Women’s Health Update

Long Island Woman, March 2020

Former SWHR Communications Director Emily Ortman discusses overcoming bias against women in pain management and the need for more funding to research pain conditions that disproportionately affect women like migraine.

Research: Sexism Has Always Colored Health Care — to the Point of Keeping Women Unhealthy

The Swaddle, January 25, 2020

An edited excerpt from the new book Pain and Prejudice by Gabrielle Jackson details women’s historical exclusion from research and the harmful results and mentions the role of SWHR in advocating for change.

It Might Take a Century to Achieve Gender Parity. Here’s How to Help Speed It Up.

Mashable, December 18, 2019

A report from the World Economic Forum finds that at the current rate of change, we’ll need to wait another hundred years before achieving global gender parity. To speed things, this article recommends supporting organizations like SWHR that are working to advance women’s interests.

The Female Problem: How Male Bias in Medical Trials Ruined Women’s Health

The Guardian, November 13, 2019

Another published excerpt from Gabrielle Jackson’s book Pain and Prejudice mentioning how SWHR teamed up with some U.S. Congress members in order to draw attention to the discrepancies in medical research and the effect on women’s health.

Exploring Gender Bias in Healthcare

FierceHealthcare, September 16, 2019

This article summarizing the dangers of gender bias in areas of medicine like cardiovascular disease, mental health, and pain conditions quotes Former SWHR CEO Dr. Amy M. Miller on how women’s pain is often initially dismissed by health care providers.

The Ultimate Guide to Dealing With Menopause

Oprah Magazine, September 10, 2019

Former SWHR CEO Dr. Amy M. Miller expresses frustration that not as much attention is given to treating women’s conditions like hot flashes due to menopause as is given to men’s conditions like erectile dysfunction.

Medicine Ignored Women’s Health for Years — That’s Finally Changing

New York Post, August 5, 2019

Former SWHR CEO Dr. Amy M. Miller and Former Board Member Dr. Nieca Goldberg share their women’s health expertise in this article about how the medical field dismissed female health concerns for decades. Goldberg says she often sees women who have had their concerns dismissed by another doctor.

Is Bias Keeping Female, Minority Patients from Getting Proper Care for Their Pain?

Washington Post, July 29, 2019

Former SWHR CEO Dr. Amy M. Miller comments on the dismissal and normalization of women’s pelvic pain for this article about disparities in care for chronic pain.

When Doctors Dismiss Your Symptoms as Perimenopause

Prevention, July 23, 2019

Sometimes doctors may over-attribute symptoms in middle-age women as related to perimenopause, causing these women to wait longer for diagnoses and treatment of other health conditions. Part of the problem stems from the fact that “Female-only conditions like menopause have long been ignored by scientists,” SWHR’s former CEO Dr. Amy M. Miller tells Prevention.

Pharmacists Improve Public Health By Focusing on Women

Pharmacy Today, July 2019

Progress has been made over the decades to include women in clinical trials and improve research on women, former SWHR CEO Dr. Amy M. Miller explains in this  article. Though, research on drug safety and efficacy has not been sufficient for pregnant and breastfeeding women. This article discusses how pharmacists can step in and provide much-needed care to women.

Femtech Could Be the Solution to Medicine’s Male Bias

OneZero, May 16, 2019

Scientists have traditionally regarded men as the default patient. “This created a huge gap in knowledge about women’s health and the ways in which women’s biology and health needs differ from men’s,” former SWHR CEO Dr. Amy M. Miller explains to OneZero, a new science and technology publication by Medium.

‘All in Your Head’? Getting Care for Untreated Pain

Consumer Reports, May 2, 2019

Doctors are more likely to dismiss pain symptoms based on patients’ race, gender, and age. For women with pelvic pain caused by conditions such as endometriosis and fibroids, they are commonly told their pain is just a normal part of being a woman, former SWHR CEO Dr. Amy M. Miller explains.

Men Are From Mars, Women Are From … Well, We Don’t Really Know

Reservoir Communications Group, May 1, 2019

We’re in the golden age of biomedical progress, and yet women’s health still presents many mysteries to the scientific community, SWHR Board Member Gretta Stone writes in a blog post.

Why Are So Many Women Rejecting Medical Science?

DAME magazine, April 22, 2019

When it comes to the differences between men and women, “There’s a lot we don’t know,” former SWHR CEO Dr. Amy M. Miller says in this article exploring science’s failure to study women’s health. “We only started including women in research 15 or 20 years ago and that means a lot of generic drugs may not have been investigated in women. We don’t know if a drug isn’t as effective in a woman’s body as it is in a man’s.”

What Do We Know About the Effects of Oral Contraceptives on the Brain?

Globe and Mail, April 1, 2019

Former SWHR CEO Dr. Amy M. Miller explains that the knowledge gap around the effects of oral contraceptives is part of a broader historical lack of research into women’s health in general.

FDA Accepts Feedback On VALID, Clinical Lab Test Lobby Encouraged

Inside Health Policy, March 28, 2019

Former SWHR CEO Amy M. Miller comments on the VALID Act, noting that its latest product of a years-­long effort to draw up FDA regulations in the diagnostics space. She said much of the industry’s hesitation with the discussion draft comes from the relatively new concept of precertification.

Why Women Are Diagnosed With Diseases Later Than Men

Healthline, March 20, 2019

A new study shows women were diagnosed later than men in more than 700 diseases. “When we ask why are there these disparities, I think it’s because we’ve ignored women’s health for so long,” former SWHR CEO Dr. Amy M. Miller told Healthline.

Healthcare Stakeholders Ask CMS Not to Limit Access to NGS Hereditary Cancer Risk Tests

GenomeWeb, February 1, 2019

SWHR wrote to the Centers for Medicare & Medicaid Services requesting the agency change its decision to restrict coverage of next-generation sequencing-based testing for hereditary cancer risk. GenomeWeb cited SWHR’s letter expressing concerns that CMS’ guidance will deny women access to tests that could profoundly improve their health outcomes and survival rates.